Evidence map›Paper›PMID 41341006›Full record

Article3D printing and additive manufacturing2025

Melt-Extrusion Additive Manufacturing for Tissue Engineering: Applications and Limitations.

Andrea Roberto Calore, Carlos Mota, Katrien Bernaerts, Jules Harings, Lorenzo Moroni

Abstract read
In one paragraph

Article in 3D printing and additive manufacturing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea Roberto CaloreMERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
Carlos MotaMERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0003-1263-9250
Katrien BernaertsAachen-Maastricht Institute for Biobased Materials (AMIBM), Maastricht University, Geleen, The Netherlands.
Jules HaringsAachen-Maastricht Institute for Biobased Materials (AMIBM), Maastricht University, Geleen, The Netherlands.
Lorenzo MoroniMERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0003-1298-6025

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of additive manufacturing techniques has increased over the years in almost all production fields, thanks to the possibility of creating objects from scratch and with the desired shape, with no need for molds or complex machinery typical of subtractive manufacturing. This success has concerned the biomedical world as well, where melt-based methods represent the golden standard to produce scaffolds for hard-tissue engineering. Despite the large number of studies present in the literature on scaffold production, the fabrication process is still affected by drawbacks and limitations, which hinders the standardization and upscaling to the industrial level. In this review, we briefly present the history of additive manufacturing and the reasons of its success, with particular reference to the tissue engineering and regenerative medicine world. We then proceed to highlight the current factors limiting the straightforwardness of the production process and affecting the quality and the performance of the manufactured scaffolds. Eventually, we suggest potential strategies to increase the level of control during manufacturing and to improve the biomimicry of the fabricated constructs, with the goal of obtaining a more optimal workflow.

Indexed as

additive manufacturingmelt-extrusionscaffoldstissue engineering

Identifiers

PMID41341006
PMCPMC12670683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.